3 results
1. To investigate the tolerability and safety of HALF-MIS used in elderly patients with chronic musculoskeletal pain.2. To investigate the effect on pain of HALF-MIS used in elderly patients with chronic musculoskeletal pain.3. To investigate the…
The primary objectives are to determine the maximum tolerated dose (MTD) and/or recommended phase two dose (RP2D) of ABBV-621 and to evaluate pharmacokinetics (PK) of (A) single agent ABBV-621; and (B) the combination of ABBV-621 and venetoclax in…
The primary objective of this study is to evaluate the performance of the Navigate Anti-AAV9 Antibody Assay using serum specimens in subjects with SMA in Novartis clinical studies COAV101B12301 *STEER* and COAV101B12302 *STRENGTH*.